Biotech and life sciences occupiers in São Paulo typically cluster in Vila Olímpia & Berrini, plan ~320 sqft per seat at high-end fit-out ($1900–2800/sqft), and pay around 250 BRL/sqft ($56 USD) on Class A.
Biotech and life sciences occupiers in São Paulo typically cluster in Vila Olímpia & Berrini, plan ~320 sqft per seat at high-end fit-out">fit-out ($1900–2800/sqft), and pay around 250 BRL/sqft ($56 USD) on Class A.
Biotech and life sciences occupiers in São Paulo typically anchor in Vila Olímpia & Berrini. Tech, consulting, banking, retail HQs, telecom.
Class A rent in São Paulo runs 250 BRL/sqft ($56 USD) on a 5-year lease with 6 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $1900–2800/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in São Paulo typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deep banking, professional services, and tech talent. Strong feed from USP, FGV, Insper, and ITA. Portuguese-English bilingual professional base in international corporate.
Headline corporate tax: 34%. Net leases. 5-year terms standard with statutory renewal rights under Brazilian commercial lease law (Lei do Inquilinato). Free rent of 4-9 months and TI of BRL 600-1,200/sqm typical.
| city | São Paulo |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | Vila Olímpia & Berrini |
| preferredFitoutSpec | High-end |
| fitoutBand | $1900–2800/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 250 BRL/sqft/yr |
| classARentUsd | $56/sqft/yr |
| vacancyPct | 19.4% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 6 |
| talentIndex | 80 |
| corporateTaxPct | 34% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.